D. E. Shaw & Co., Inc. Compugen LTD Transaction History

D. E. Shaw & Co., Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $58,791 - $206,660	89,078 New	89,078 $59,000
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $78,134 - $165,724	-49,767 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.76 - $4.64 $137,356 - $230,918	49,767 New	49,767 $160,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $248,483 - $434,998	-60,754 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $352,373 - $487,247	60,754 New	60,754 $363,000
Q1 2021 May 17, 2021	SELL	$7.67 - $13.77 $124,146 - $222,881	-16,186 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.07 - $17.95 $223,850 - $332,900	-18,546 Reduced 53.4%	16,186 $196,000
Q3 2020 Nov 16, 2020	BUY	$14.16 - $19.45 $491,805 - $675,537	34,732 New	34,732 $564,000
Q1 2020 May 15, 2020	SELL	$5.79 - $11.83 $471,520 - $963,399	-81,437 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.9 - $6.16 $111,555 - $176,200	28,604 Added 54.14%	81,437 $486,000
Q3 2019 Nov 14, 2019	BUY	$3.01 - $4.49 $123,837 - $184,727	41,142 Added 351.91%	52,833 $224,000
Q2 2019 Aug 14, 2019	BUY	$2.8 - $4.14 $32,734 - $48,400	11,691 New	11,691 $45,000
Q4 2017 Feb 14, 2018	SELL	$2.35 - $4.0 $28,890 - $49,176	-12,294 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.75 - $3.95 $33,808 - $48,561	12,294	12,294 $47,000

13.4M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $152M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.